00
00897.TW Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF
- TWD
No recent price
- Total assets
- 1.87B
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- +75.91%
- Holdings
- 10
- Since
- 2021
Fund data as reported by the issuer, updated Nov 8, 2026. Total assets are in the fund's base currency.
What does 00897.TW invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (66.3%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (70.1%)
- Top 3 holdings: 22.9% of the fund
Asset allocation
- US stocks 66.3%
- Non-US stocks 29.5%
- Cash 3.4%
Top holdings
- Moderna Inc 10.64%
- Twist Bioscience Corp 7.42%
- Iovance Biotherapeutics Inc 4.81%
- Genmab A/S 4.01%
- Revolution Medicines Inc 3.88%
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF performance
Sharpe ratio 1.19- This year
- +66.06%
- 1 year
- +75.91%
- 3 years
- +30.74%
- 5 years
- -0.76%
Volatility 25.5% over 1 year and 22.6% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
00897.TW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF top holdings
47.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 10.64% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 7.42% |
| Iovance Biotherapeutics Inc IOVA.US | Healthcare | United States | 4.81% |
| Genmab A/S GMAB.CO | Healthcare | Denmark | 4.01% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 3.88% |
| Bayer AG NA BAYN.XETRA | Healthcare | Germany | 3.60% |
| Takeda Pharmaceutical Co. Ltd. 4502.TSE | Healthcare | Japan | 3.28% |
| Merck & Company Inc MRK.US | Healthcare | United States | 3.25% |
| Incyte Corporation INCY.US | Healthcare | United States | 3.21% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 3.17% |
00897.TW sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
00897.TW regional exposure
- North America70.1%
- Europe Developed16.8%
- Japan4.9%
- United Kingdom2.6%
- Asia Emerging1.8%
- Asia Developed0.2%
Share of the stocks in the fund.
Company size
Average market cap 566B- Mega cap11.0%
- Big cap13.7%
- Medium cap32.3%
- Small cap22.1%
- Micro cap17.8%
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF fund profile
- Fund name
- Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF
- Ticker
- 00897.TW
- Exchange
- Taiwan Stock Exchange
- Issuer
- -
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Inception date
- Sep 24, 2021
- Trading currency
- TWD
- Expense ratio
- -